Our in vitro experiments in glioma cells confirmed that changes in the expression of CRNDE and miR-136-5p result in changes in Wnt2 and Bcl-2 expression at the mRNA and protein levels, although our study did not provide direct evidence for the corresponding miRNA/mRNA interactions. The gene discussed is CRNDE; the disease is central nervous system cancer.